This year’s ISPE Biopharmaceutical Manufacturing Conference promises to deliver excellent content and is a must attend for anyone involved in the manufacture of biotech drugs in today’s fast changing environment. Building on the success of our previous conferences this ISPE signature event will cover every aspect from quality, regulatory, drug substance, to drug product, with an emphasis on advanced therapeutic medicinal products including CAR-T, cell and gene therapy, and personalized cancer vaccines. This conference will cover the waterfront from personalized medicines, oligonucleotides, and emerging technologies including continuous manufacturing.
Speakers include industry leaders in manufacturing, quality, regulatory, and academia. This includes prominent FDA speakers from both CBER and CDER. Presentations will be followed by interactive discussions on the challenges and opportunities in truly producing personalized medicines - one patient, one product, covering:
The pharma industry is already under transformation and much more is on the way. Whether you are in a small or large company, start-up or major biopharmaceutical manufacturer, are new or very experienced in the industry, this conference is necessary for you to attend to keep pace with the advancements the industry is bringing in manufacturing technology, newer products, and ultimately patient treatments.
Unlike other Biopharmaceutical manufacturing conferences you may have attended, this conference has a faculty bringing scientific, manufacturing, academic, and health authority experience, and is backed by ISPE’s body of knowledge represented by our expert committees and publications including our Baseline Guides and Good Practice Guides.
There is still time to register however it is getting close so reserve your spot now. If you were waiting for a special invitation, this is it!
To meet the biopharmaceutical industry’s duty to manufacture safe and effective therapies for patients, a robust quality system is fundamental to success. A quality system should link to quality culture and prioritize focusing on quality, led by management, that fosters sustainable compliance and consistent production of high-quality drugs. Strong quality culture attributes include a proactive...
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...